Provider Lawsuit Could Tie Up
Surprise Billing Regulations
The U.S.’s two largest health care provider groups, the American
Medical Association (AMA) and the American Hospital Association (AHA), sued the Biden administration on Dec. 9, asking a federal
court to block regulations officials developed to implement the No Surprises
Act, parts of which will come into effect on Jan. 1. Health care attorneys tell
AIS Health that the suit may hinge on the providers’ allegation that federal
officials stretched their legal authority too far beyond the Act’s original
intent — and that the providers might win.
Providers Argue QPA Favors Insurers
- The AMA and AHA seek an emergency injunction blocking
implementation of the Biden admin’s Oct. 7 interim final rule. Legal experts tell AIS Health
that such an injunction could come shortly after the new year. However, if
the case goes to trial, it could take years to be resolved, especially if
it is appealed.
- Health care attorneys tell AIS Health that the
providers’ legal argument centers on the IFR’s guidance on qualified
payment amounts (QPAs). QPA is a metric created in the No Surprises Act
that is largely based on median in-network reimbursement rates and is one
of several factors that arbitrators must consider when deciding a balance
billing dispute.
- “The crux of it is the QPA, which gives the insurers
more say in what’s going to be one of the major factors in the dispute
resolution process,” explains Raja Sékaran, a health care attorney and
partner at Nossaman LLP.
- Sékaran says this argument reveals a real ambiguity.
HHS has some leeway in issuing regulations — the question for the judge is
how much.
- “I think it’s fair to say in rulemaking, they should
try to improve the process and add to the process any sort of detail that
could cut down on waste and increase efficiency….It could lead to many
different outcomes….[The No Surprises Act] may create its own area of
regulatory administrative law in terms of the outcomes,” Sékaran says.
Public May Lose If Providers Win
- Loren Adler, an economist and the associate director of
the USC-Brookings Schaeffer Initiative for Health Policy, tells AIS Health
that deemphasizing the QPA would be bad for the public.
- “[The AMA and AHA] think if there is less clear
guidance in the arbitration decisions…they will make more money,” Adler
tells AIS Health. “In turn, consumers will pay higher premiums. That is
the central thing they are arguing for.”
- Adler also doesn’t buy the argument that the emphasis
on QPA contradicts Congress’ intent. “To somehow expect the cost sharing
to systematically diverge from the actual payment would be sort of odd.
[The Congressional Budget Office’s] assumptions very clearly rest on
arbitration decisions coming out roughly at the QPA.””
No comments:
Post a Comment